• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • Global health

    Opinion: How do we turn the tide on this cholera pandemic?

    We are at a crucial point in the fight against cholera. Despite shortages and rising demand, there is real momentum in vaccine development and production. We can’t afford to lose focus.

    By Giulia Balconi // 30 October 2024

    Related Stories

    Can innovative models close financing gaps for neglected disease R&D?
    Can innovative models close financing gaps for neglected disease R&D?
    How Asia-Pacific can boost vaccine access in the next pandemic
    How Asia-Pacific can boost vaccine access in the next pandemic
    Gavi's board tasked with strategy shift in light of $3B funding gap
    Gavi's board tasked with strategy shift in light of $3B funding gap
    How Gavi is reaching ‘zero-dose’ children in conflict areas
    How Gavi is reaching ‘zero-dose’ children in conflict areas

    While most people remain unaware, we are in the midst of a cholera pandemic that has ravaged lives since 1961. It’s the world’s seventh such pandemic, which began in Indonesia, spread to 45 countries, and now puts millions at risk every year.

    Among global development professionals, we know this killer well. But to the general public, cholera is often seen as a disease of the past — evoking images of Victorian London, dirty streets, and free-flowing sewage. In reality, cholera is a modern-day tragedy in regions with limited resources, and it demands our full attention.

    Cholera, an acute diarrheal infection caused by the bacterium Vibrio cholerae and spread through contaminated food and water, persists despite all we’ve learned about the importance of clean water and sanitation and the advancements we’ve made with highly effective vaccines.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    Read more:

    ► Cholera thrives in a warming world

    ► How Pakistan's massive floods sparked Malawi's record cholera outbreak

    ► Opinion: Could schools be the syndromic surveillance hubs we need?

    • Global Health
    • Innovation & ICT
    • Private Sector
    • Funding
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the author

    • Giulia Balconi

      Giulia Balconi

      Giulia Balconi supports research efforts at Adjuvant Capital, an impact investment firm supporting life sciences technology companies focused on historically neglected diseases and maternal/child health. She holds a master's degree in Public Health from UC Berkeley.

    Search for articles

    Related Stories

    Global healthRelated Stories - Can innovative models close financing gaps for neglected disease R&D?

    Can innovative models close financing gaps for neglected disease R&D?

    Global healthRelated Stories - How Asia-Pacific can boost vaccine access in the next pandemic

    How Asia-Pacific can boost vaccine access in the next pandemic

    Global HealthRelated Stories - Gavi's board tasked with strategy shift in light of $3B funding gap

    Gavi's board tasked with strategy shift in light of $3B funding gap

    Global healthRelated Stories - How Gavi is reaching ‘zero-dose’ children in conflict areas

    How Gavi is reaching ‘zero-dose’ children in conflict areas

    Most Read

    • 1
      Opinion: 5 visionaries, 1 mission — transforming maternal health
    • 2
      Toward a lead-free future: The case for action now
    • 3
      Opinion: An industry playbook for addressing NCDs in LMICs
    • 4
      Opinion: It’s time. Women have waited long enough
    • 5
      Strengthening maternal health through sustainable investment
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement